Why the study?
Does serial electropharmacological testing prevent sudden death or recurrence of cardiac arrest in survivors of VT/VF?
Population
11 patients who survived an episode of cardiac arrest due to ventricular tachycardia or ventricular…
Comparison
Serial acute drug testing to select an effective… vs Empiric antiarrhythmic therapy
Design
Case_series
Follow-up
mean 14 months (range: 3-28)
Authors
Loading...
Small case series supports guided therapy in arrest survivors; leaves open need for controlled trials before adoption.
Does serial electropharmacological testing prevent sudden death or recurrence of cardiac arrest in survivors of VT/VF?
Serial electropharmacological testing is useful in selecting an effective long-term antiarrhythmic drug regimen to prevent sudden death in survivors of cardiac arrest.
Raviele et al. (1984) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: